PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
08-Jan-2024 Eckert & Ziegler and ARTBIO Announce Manufacturing and Supply Partnership for Lead-212 Conjugates Eckert & Ziegler Strahlen- und Medizintechnik AG
08-Jan-2024 MorphoSys to Present at the 42nd Annual J.P. Morgan Healthcare Conference  MorphoSys AG
08-Jan-2024 Calypso Enters into Agreement to Be Acquired by Novartis B3C newswire
08-Jan-2024 Evotec announces progress in strategic neuroscience partnership with Bristol Myers Squibb Evotec SE
05-Jan-2024 CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform CureVac
04-Jan-2024 Formycon to present at the 42nd Annual J.P. Morgan Healthcare Conference Formycon AG
04-Jan-2024 PharmaKure granted MHRA Clinical Trial Authorisation (CTA) for PK051 for the treatment of mild cognitive impairment due to Alzheimer’s Disease PharmaKure
04-Jan-2024 Vicore Reports Positive Results for the Pivotal Study of its Digital Therapy for Patients with Pulmonary Fibrosis Vicore Pharma Holding AB (publ)
04-Jan-2024 Biocomposites’ investee Renovos Biologics receives FDA Breakthrough Device Designation for its synthetic nanoclay bone fusion gel, RENOVITE® BMP-2 Biocomposites
04-Jan-2024 Aptar Digital Health and Gerresheimer Collaborate to Develop Integrated Solution for Subcutaneous Cancer Therapy Aptar Digital Health
04-Jan-2024 Vicore Confirms IPF Development Program on Track and Provides Early-Stage Pipeline Updates Vicore Pharma Holding AB
04-Jan-2024 Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenamide Newron Pharmaceuticals
04-Jan-2024 Gerresheimer AG: Gerresheimer and Aptar Digital Health collaborate to develop integrated solution for cancer therapy  Gerresheimer AG
04-Jan-2024 TRYP THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 2a CLINICAL TRIAL FOR THE TREATMENT OF FIBROMYALGIA AT THE UNIVERSITY OF MICHIGAN Tryp Therapeutics Inc.
04-Jan-2024 Abivax 2024 Financial Communication Calendar ABIVAX
04-Jan-2024 Evotec and Owkin enter an A.I.-powered strategic partnership to accelerate therapeutics pipeline in oncology and I&I Evotec SE
04-Jan-2024 Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia (TRS) Newron Pharmaceuticals S.p.A.
04-Jan-2024 Kuros Biosciences Announces Three Advancements Related to its MagnetOsTM Portfolio Including Impressive Fusion Data from MAXA Prospective Randomized Clinical Trial and Two 510(k) Clearances from FDA Kuros Biosciences AG
03-Jan-2024 Evotec announces CEO transition Evotec SE
03-Jan-2024 Evotec announces CEO transition Evotec SE